We wanted to further investigate the hypothesis that prion diseases share a common mechanism of neurodegeneration with other brain amyloidosis, and set out to study the toxicity of PrP oligomers in vitro and in vivo in the presence or absence of endogenous PrP expression. This evidence concerns the gene PRNP and prion disease.